KU 210 (Montelukast sodium 10 mg (base))

Pill imprint KU 210 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium

Imprint:

KU 210

Strength:

10 mg (base)

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Leukotriene modifiers

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Kremers Urban Pharmaceuticals Inc.

National Drug Code (NDC):

62175-0210

Inactive Ingredients:

silicon dioxide
croscarmellose sodium
hydroxypropyl cellulose (type h)
mannitol
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
sodium stearyl fumarate
magnesium silicate
titanium dioxide

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
42291-0621	AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.